125 related articles for article (PubMed ID: 19086169)
21. Strong PDGFRA positivity is seen in GISTs but not in other intra-abdominal mesenchymal tumors: Immunohistochemical and mutational analyses.
Peterson MR; Piao Z; Weidner N; Yi ES
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):390-6. PubMed ID: 17122634
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
23. Rectal GIST presenting as a submucosal calculus.
Testroote M; Hoornweg M; Rhemrev S
Dig Dis Sci; 2007 Apr; 52(4):1047-9. PubMed ID: 17268837
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA involvement in gastrointestinal stromal tumor tumorigenesis.
Kim WK; Yang HK; Kim H
Curr Pharm Des; 2013; 19(7):1227-35. PubMed ID: 23092343
[TBL] [Abstract][Full Text] [Related]
25. [Gastrointestinal stromal tumor (GIST): imaging findings and differential diagnosis].
Zubler Ch; Fahrni M; Komminoth P; Kocher T; Kubik-Huch RA
Praxis (Bern 1994); 2007 May; 96(21):859-63. PubMed ID: 17569438
[TBL] [Abstract][Full Text] [Related]
26. Management of endocrine disease: a clinical update on tumor-induced hypoglycemia.
Iglesias P; Díez JJ
Eur J Endocrinol; 2014 Apr; 170(4):R147-57. PubMed ID: 24459236
[TBL] [Abstract][Full Text] [Related]
27. C-KIT and PDGFRA zygosity in gastrointestinal stromal tumors: Correlation with tumor site, tumor size, exon, and CD117 immunohistochemistry.
Wallander ML; Willmore-Payne C; Layfield LJ
Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):21-7. PubMed ID: 20823768
[TBL] [Abstract][Full Text] [Related]
28. Imatinib-induced pathologic changes including bile duct dilatation in hepatic metastases of gastrointestinal stromal tumor: case report and review of literature.
Lee YS; Lee SH; Choi YJ; Jung ES
J Cancer Res Ther; 2014; 10(3):763-6. PubMed ID: 25313780
[TBL] [Abstract][Full Text] [Related]
29. Synchronous and metachronous multiple gastrointestinal stromal tumors.
Xu C; Liu YL; Yu HY; Hou YY; Lu SH; Zhao LJ; Zhou Y; Shi Y; Tan YS; Zhu XZ
Histol Histopathol; 2012 Feb; 27(2):225-34. PubMed ID: 22207557
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal stromal tumor with nephrotic syndrome as a paraneoplastic syndrome: a case report.
Takane K; Midorikawa Y; Yamazaki S; Kajiwara T; Yoshida N; Kusumi Y; Takayama T
J Med Case Rep; 2014 Mar; 8():108. PubMed ID: 24669929
[TBL] [Abstract][Full Text] [Related]
31. [Molecular mechanisms of primary and secondary resistance, molecular-genetic features and characteristics of KIT/PDGFRA non-mutated GISTs].
Kalfusová A; Kodet R
Cesk Patol; 2017; 53(4):167-173. PubMed ID: 29227120
[TBL] [Abstract][Full Text] [Related]
32. [Therapeutic targets in gastrointestinal stromal tumors].
Wardelmann E; Schildhaus HU; Merkelbach-Bruse S; Büttner R
Verh Dtsch Ges Pathol; 2006; 90():73-9. PubMed ID: 17867582
[TBL] [Abstract][Full Text] [Related]
33. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
34. A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation.
Elston MS; Sehgal S; Dray M; Phillips E; Conaglen JV; Clifton-Bligh RJ; Gill AJ
J Clin Endocrinol Metab; 2017 May; 102(5):1447-1450. PubMed ID: 28324028
[TBL] [Abstract][Full Text] [Related]
35. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].
Beliakov IS; Anurova OA; Snigur PV; Tsyganova IV; Sel'chuk VIu; Mazurenko NN
Vopr Onkol; 2007; 53(6):677-81. PubMed ID: 18416137
[TBL] [Abstract][Full Text] [Related]
36. Remarkable effects of imatinib in a family with young onset gastrointestinal stromal tumors and cutaneous hyperpigmentation associated with a germline KIT-Trp557Arg mutation: case report and literature overview.
Farag S; van der Kolk LE; van Boven HH; van Akkooi ACJ; Beets GL; Wilmink JW; Steeghs N
Fam Cancer; 2018 Apr; 17(2):247-253. PubMed ID: 28710566
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
38. [Gastrointestinal stromal tumors (GIST). Clinical characteristics, diagnosis, and therapy in five cases].
Ludolph T; Schweitzer A; Bremer A; Schulz U; Glasbrenner B
Med Klin (Munich); 2006 Jan; 101(1):69-74. PubMed ID: 16418817
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal stromal tumors.
Antonescu C
Curr Top Microbiol Immunol; 2012; 355():41-57. PubMed ID: 22015552
[TBL] [Abstract][Full Text] [Related]
40. Metastatic Liver Disease Associated with Gastrointestinal Stromal Tumors: Controversies in Diagnostic and Therapeutic Approach.
Mastoraki A; Toliaki E; Chrisovergi E; Mastoraki S; Papanikolaou IS; Danias N; Smyrniotis V; Arkadopoulos N
J Gastrointest Cancer; 2015 Sep; 46(3):237-42. PubMed ID: 26163021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
